Abbott Laboratories Stock Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.06 EUR | +2.31% |
|
+3.36% | -14.06% |
| Jul. 24 | Abbott defeats shareholder lawsuit over 2022 infant formula recall | RE |
| Jul. 24 | Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall | RE |
| Market Cap | 180B 158B 147B 135B 253B 17,287B 257B 1,741B 680B 8,499B 674B 659B 29,385B | P/E 2026 * |
29.2x | P/E 2027 * | 22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 203B 178B 166B 152B 286B 19,539B 290B 1,968B 769B 9,606B 762B 745B 33,213B | EV / Sales 2026 * |
4.03x | EV / Sales 2027 * | 3.57x |
| Free-Float |
86.73% | Yield 2026 * |
2.51% | Yield 2027 * | 2.64% |
Last Transcript: Abbott Laboratories
| 1 day | +2.31% | ||
| 1 week | +3.36% | ||
| Current month | +13.63% | ||
| 1 month | +10.27% | ||
| 3 months | +16.71% | ||
| 6 months | -0.75% | ||
| Current year | -14.06% |
| 1 week | 87.48 |  | 91.06 |
| 1 month | 76.98 | | 91.06 |
| Current year | 70.1 | | 109.64 |
| 1 year | 70.1 | | 116.14 |
| 3 years | 70.1 | | 134.2 |
| 5 years | 70.1 | | 134.2 |
| 10 years | 49.6 | | 134.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.31% | +3.36% | - | - | 180B | |
| +1.46% | +0.01% | -10.47% | -6.46% | 107B | |
| +1.58% | +0.65% | +6.73% | +61.49% | 60.29B | |
| -1.13% | -2.60% | +27.02% | +55.00% | 50.19B | |
| +2.22% | -1.14% | -15.63% | -44.81% | 43.08B | |
| +2.98% | -2.61% | - | - | 32.77B | |
| +1.50% | -6.67% | -19.61% | -44.95% | 27.61B | |
| -7.67% | -8.39% | +24.55% | -12.97% | 23.1B | |
| +1.63% | -1.73% | -7.11% | -8.13% | 20.86B | |
| +0.30% | -4.54% | -16.36% | -2.68% | 19.5B | |
| Average | +0.52% | -3.00% | -1.36% | -0.44% | 42.66B | |
| Weighted average by Cap. | +1.25% | -1.89% | -1.33% | +5.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.29B 44.17B 41.07B 37.69B 70.82B 4,843B 71.91B 488B 191B 2,381B 189B 185B 8,232B | 54.63B 47.98B 44.62B 40.95B 76.93B 5,261B 78.12B 530B 207B 2,586B 205B 201B 8,943B |
| Net income | 6.32B 5.55B 5.16B 4.74B 8.9B 609B 9.04B 61.29B 23.95B 299B 23.72B 23.21B 1,034B | 7.94B 6.98B 6.49B 5.95B 11.19B 765B 11.36B 77.06B 30.1B 376B 29.82B 29.18B 1,300B |
| Net Debt | 23.38B 20.54B 19.1B 17.52B 32.93B 2,252B 33.44B 227B 88.6B 1,107B 87.77B 85.88B 3,827B | 15.74B 13.83B 12.86B 11.8B 22.17B 1,516B 22.51B 153B 59.66B 745B 59.1B 57.83B 2,577B |
| Date | Price | Change |
|---|---|---|
| 26-07-24 | €91.06 | +2.31% |
| 26-07-23 | €89.00 | +1.21% |
| 26-07-22 | €87.94 | -2.94% |
| 26-07-21 | €90.60 | +1.96% |
| 26-07-20 | €88.86 | +0.86% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
